跳至主要内容
临床试验/NCT03860545
NCT03860545已完成不适用

The New Biochemical Markers of Cardiac Surgery Related Acute Kidney Injury.

Pomeranian Medical University Szczecin1 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2018年1月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
88
试验地点
1
主要终点
acute kidney injure after operation

研究概览

简要总结

Cardiac surgery related acute kidney injury (CS-AKI) is a clinical problem associated with a cardiopulmonary bypass used during cardiac surgery procedures. In this study the investigators will assess the biochemical markers of acute kidney injury such as ischemia modified albumin (IMA) or urinary excreted of brush-border enzymes of the proximal renal tubules perioperatively. There has been no official recommendations toward routine use of analysed biomarkers.

详细描述

Cardiac surgery related acute kidney injury (CS-AKI) is an important clinical problem. Kidney injury occurs following a cardiopulmonary bypass used during cardiac surgery procedures. The pathomechanisms of acute kidney injury (AKI) is complex and multifactorial. It may involve few injury pathways: ischemia and reperfusion, endogenous toxins, inflammation, metabolic factors and oxidative stress. Biochemical markers of acute kidney injury such as ischemia modified albumin (IMA) or urinary excreted of brush-border enzymes of the proximal renal tubules analysed perioperatively will be assessed in this study. There has been no official recommendations toward routine use of analysed biomarkers.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • a planned operation of coronary artery bypass grafting with the use of cardiopulmonary bypass

排除标准

  • emergency operations or re-operations;
  • a known pathology of the urinary tract or renal failure;
  • chronic use of the following medications: iron, non-steroidal anti-inflammatory drugs (NSAIDs), immunosuppression, or steroids in the preoperative period;
  • polycythemia, porphyria or pathological hemoglobin species in anamnesis;
  • preoperative signs of hepatic failure;
  • active autoimmune or neoplastic diseases, active infection;
  • anticipated significant bleeding (anti-platelet agents), suggesting the use of blood-derived products during the operation and afterward
  • acute myocardial infarction after operation

结局指标

主要结局

acute kidney injure after operation

时间窗: up to 48 hours post operation

acute kidney injure measured by urine output in ml

次要结局

未报告次要终点

研究者

发起方
Pomeranian Medical University Szczecin
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jowita Biernawska

MD PhD

Pomeranian Medical University Szczecin

研究点 (1)

Loading locations...

相似试验